Next frontier in study of gut bacteria: mining microbial molecules Yale NewsUsing the chemical screening technology PRESTO-Tango, Yale researchers have identified specific gut bacteria that impact various aspects of human biology.
Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression PRNewswireNAPLES, Fla., April 18, 2019 /PRNewswire/ -- Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a sublingual antidepressant ...
Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression P&T CommunityNAPLES, Fla., April 18, 2019 /PRNewswire/ -- Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a sublingual antidepressant ...
Avoiding Withdrawal Syndrome for SSRIs Requires Months, Not... : Neurology Today LWW JournalsHurley, Dan. Neurology Today: April 18, 2019 - Volume 19 - Issue 8 - p 41–47. doi: 10.1097/01.NT.0000558056.34793.96. For Your Patients. Article Outline ...
Brain scans help shed light on the PTSD brain, but they cannot diagnose PTSD Thehour.com(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Arash Javanbakht, Wayne State ...
Brain scans help shed light on the PTSD brain, but they cannot diagnose PTSD Torrington Register Citizen(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Arash Javanbakht, Wayne State ...
Nose spray that could help treat depression IOLThe spray gets to work in as little as two hours, far quicker than widely used medications that can take weeks to kick in.
FDA Warns Against Direct-to-Consumer Lab Developed Tests LexologyDespite it being a continual topic of discussion, the Food and Drug Administration (FDA) enforcement in the realm of laboratory developed tests (LDTs)…
Why does Ketamine Fight Depression? Finding Answers at BNA 2019 Technology NetworksMajor depressive disorder (MDD) affects roughly 350 million people worldwide, but a significant minority of patients don't respond to currently available ...
